thromboxanes has been researched along with Atrial Fibrillation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurbel, PA; Navarese, EP; Tantry, US | 1 |
| Egom, EE | 1 |
| Bartimoccia, S; Carnevale, R; Farcomeni, A; Nocella, C; Pastori, D; Pignatelli, P; Violi, F | 1 |
| Bunin, IuA; Nargizian, AB; Petrovskiĭ, PF; Smirnov, IE; Ziabkina, AG | 1 |
4 other study(ies) available for thromboxanes and Atrial Fibrillation
| Article | Year |
|---|---|
Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?
Topics: Atrial Fibrillation; Cardiovascular Diseases; Humans; Proprotein Convertase 9; Risk Factors; Thromboxanes | 2017 |
LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Cholesterol, LDL; Humans; Proprotein Convertase 9; Thromboxanes | 2018 |
Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?
Topics: Atrial Fibrillation; Cardiovascular Diseases; Cholesterol, LDL; Humans; Proprotein Convertase 9; Thromboxanes | 2018 |
[Concentration of endogenous prostanoids and cyclic nucleotides in patients with atrial fibrillation].
Topics: Adult; Aorta, Thoracic; Atrial Fibrillation; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dinoprost; Epoprostenol; Female; Humans; Male; Middle Aged; Prostaglandins; Prostaglandins E; Prostaglandins F; Thromboxane A2; Thromboxanes | 1984 |